Wilma Heemsbergen

11PUBLICATIONS
47CO-AUTHORS
Bioinformatic methods developmentComputational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Synchrotrons and accelerators not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 08, 2025
Added Value of Biological Effective Dose in Dosiomics-Based Modelling of Late Rectal Bleeding in Prostate Cancer.

Christian A M Jongen, Wilma D Heemsbergen, Luca Incrocci

|Dec 20, 2024
Prospective Observational Study on Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer in Rwanda: Acute Toxicity in Patients.

Felix Sinzabakira, W D Heemsbergen, Pacifique Mugenzi

|Aug 28, 2023
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.

Soumyajit Roy, Tahmineh Romero, Jeff M Michalski

|Dec 28, 2022
Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma.

Gerda M Verduijn, Steven F Petit, Iris Lauwers

|Jul 26, 2022
Bladder-sparing (chemo)radiotherapy in elderly patients with muscle-invasive bladder cancer: a retrospective cohort study.

Noortje Verschoor, Wilma D Heemsbergen, Joost L Boormans

|May 28, 2021
Spatial descriptions of radiotherapy dose: normal tissue complication models and statistical associations.

Martin A Ebert, Sarah Gulliford, Oscar Acosta

Pageof 2

Frequent Collaborators

3 joint publications

Luca Incrocci

1 joint publications

Felix Sinzabakira

1 joint publications

Theoneste Maniragaba

1 joint publications

Fidel Rubagumya